FDA Inspection 1009121 — Driscoll Childrens Hospital
The FDA completed an inspection of Driscoll Childrens Hospital on March 30, 2017 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corpus Christi, TX (United States)